Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.

Autor: Griguer CE; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA., Oliva CR; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA., Coffey CS; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA., Cudkowicz ME; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Conwit RA; NINDS, National Institutes of Health, Bethesda, Maryland, USA., Gudjonsdottir AL; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA., Ecklund DJ; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA., Fedler JK; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA., Neill-Hudson TM; Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA., Nabors LB; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Benge M; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hackney JR; Department of Pathology, Division of Neuropathology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Chase M; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Leonard TP; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Patel T; Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Colman H; Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA., de la Fuente M; School of Medicine, University of Miami, Miami, Florida, USA., Chaudhary R; Department Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, USA., Marder K; Division of Neuro-Oncology, Columbia University Health Sciences, New York, New York, USA., Kreisl T; Division of Neuro-Oncology, Columbia University Health Sciences, New York, New York, USA., Mohile N; Department of Pathology, Division of Neuropathology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Chheda MG; Departments of Medicine and Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., McNeill K; Montefiore Medical Center, Bronx, New York, USA., Kumthekar P; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Dogan A; Department of Neurosurgery, Oregon Health and Science University, Portland, Oregon, USA., Drappatz J; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Puduvalli V; Department of Neuro-Oncology, Ohio State University, Columbus, Ohio, USA., Kowalska A; Department of Neurology, State University of New York, Stony Brook, New York, New York, USA., Graber J; Alvord Brain Tumor Center, Swedish Medical Center, Seattle, Washington, USA., Gerstner E; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Clark S; Department of Neurology, Vanderbilt University, Nashville, Tennessee, USA., Salacz M; Department Internal Medicine, University of Kansas Hospital, Kansas City, Kansas, USA., Markert J; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2021 Dec 24; Vol. 4 (1), pp. vdab186. Date of Electronic Publication: 2021 Dec 24 (Print Publication: 2022).